• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐相关颌骨骨坏死中疾病分期与肾功能的关系。

Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw.

作者信息

Kim Yun-Ho, Park Han-Kyul, Choi Na-Rae, Kim Seong-Won, Kim Gyoo-Cheon, Hwang Dae-Seok, Kim Yong-Deok, Shin Sang-Hun, Kim Uk-Kyu

机构信息

Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University, Yangsan, Korea.

Department of Oral Anatomy, School of Dentistry, Pusan National University, Yangsan, Korea.

出版信息

J Korean Assoc Oral Maxillofac Surg. 2017 Feb;43(1):16-22. doi: 10.5125/jkaoms.2017.43.1.16. Epub 2017 Feb 20.

DOI:10.5125/jkaoms.2017.43.1.16
PMID:28280705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5342967/
Abstract

OBJECTIVES

Bisphosphonate is the primary cause of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Bisphosphonates are eliminated from the human body by the kidneys. It is anticipated that bisphosphonate levels in the body will increase if the kidney is in a weak state or if there is systemic disease that affects kidney function. The aim of this study was to analyze the relevance of renal function in the severity of BRONJ.

MATERIALS AND METHODS

Ninety-three patients diagnosed with BRONJ in Pusan National University Dental Hospital from January 2012 to December 2014 were included in this study. All patients underwent a clinical exam, radiographs, and serologic lab test, including urine analysis. The patient's medical history was also taken, including the type of bisphosphonate drug, the duration of administration and drug holiday, route of administration, and other systemic diseases. In accordance with the guidelines of the 2009 position paper of American Association of Oral and Maxillofacial Surgeons, the BRONJ stage was divided into 4 groups, from stage 0 to 3, according to the severity of disease. IBM SPSS Statistics version 21.0 (IBM Co., USA) was used to perform regression analysis with a 0.05% significance level.

RESULTS

BRONJ stage and renal factor (estimated glomerular filtration rate) showed a moderate statistically significant correlation. In the group with higher BRONJ stage, the creatinine level was higher, but the increase was not statistically significant. Other factors showed no significant correlation with BRONJ stage. There was a high statistically significant correlation between BRONJ stage and 'responder group' and 'non-responder group,' but there was no significant difference with the 'worsened group.' In addition, the age of the patients was a relative factor with BRONJ stage.

CONCLUSION

With older age and lower renal function, BRONJ is more severe, and there may be a decrease in patient response to treatment.

摘要

目的

双膦酸盐是双膦酸盐相关颌骨坏死(BRONJ)的主要病因。双膦酸盐通过肾脏从人体排出。预计如果肾脏功能较弱或存在影响肾功能的全身性疾病,体内双膦酸盐水平将会升高。本研究的目的是分析肾功能与BRONJ严重程度之间的相关性。

材料与方法

本研究纳入了2012年1月至2014年12月在釜山国立大学牙医院诊断为BRONJ的93例患者。所有患者均接受了临床检查、影像学检查以及血清学实验室检测,包括尿液分析。还记录了患者的病史,包括双膦酸盐药物类型、给药持续时间和药物假期、给药途径以及其他全身性疾病。根据美国口腔颌面外科医师协会2009年立场文件的指南,根据疾病严重程度将BRONJ分期分为0至3期4组。使用IBM SPSS Statistics 21.0版软件(美国IBM公司)进行回归分析,显著性水平为0.05%。

结果

BRONJ分期与肾脏因素(估计肾小球滤过率)显示出中度统计学显著相关性。在BRONJ分期较高的组中,肌酐水平较高,但升高无统计学显著性。其他因素与BRONJ分期无显著相关性。BRONJ分期与“反应者组”和“无反应者组”之间存在高度统计学显著相关性,但与“病情恶化组”无显著差异。此外,患者年龄是与BRONJ分期相关的一个因素。

结论

随着年龄增长和肾功能下降,BRONJ更严重,并且患者对治疗的反应可能会降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ddf/5342967/c38fec7cf051/jkaoms-43-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ddf/5342967/c38fec7cf051/jkaoms-43-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ddf/5342967/c38fec7cf051/jkaoms-43-16-g001.jpg

相似文献

1
Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw.双膦酸盐相关颌骨骨坏死中疾病分期与肾功能的关系。
J Korean Assoc Oral Maxillofac Surg. 2017 Feb;43(1):16-22. doi: 10.5125/jkaoms.2017.43.1.16. Epub 2017 Feb 20.
2
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.静脉注射双膦酸盐相关颌骨坏死:骨闪烁显像作为早期指标
J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.
3
Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.口服双膦酸盐作为颌骨双膦酸盐相关骨坏死的一个病因:临床发现、风险评估及预防策略。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):35-43. doi: 10.1016/j.joms.2009.01.003.
4
Characteristics of bisphosphonate-related osteonecrosis of the jaw after kidney transplantation.肾移植后双膦酸盐相关颌骨坏死的特征
J Craniofac Surg. 2012 Sep;23(5):e510-4. doi: 10.1097/SCS.0b013e31825b33f6.
5
Usability of surgical treatment in cases of bisphosphonate-related osteonecrosis of the jaw stage 2 with sequestrum.手术治疗在伴有死骨的双膦酸盐相关颌骨坏死2期病例中的适用性。
Ann Maxillofac Surg. 2015 Jan-Jun;5(1):67-70. doi: 10.4103/2231-0746.161067.
6
Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.考虑原发性疾病和伴随治疗时双膦酸盐相关性颌骨骨坏死的发生率。
Anticancer Res. 2013 Sep;33(9):3917-24.
7
Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?接受口服或静脉注射双膦酸盐治疗的患者拔牙:引发药物性颌骨坏死的诱因?
J Craniomaxillofac Surg. 2015 Jul;43(6):847-54. doi: 10.1016/j.jcms.2015.03.039. Epub 2015 Apr 10.
8
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.口腔接触双膦酸盐的患者中与双膦酸盐相关的颌骨坏死:临床病程与结局
J Oral Maxillofac Surg. 2012 Aug;70(8):1844-53. doi: 10.1016/j.joms.2011.08.033. Epub 2012 May 16.
9
Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.双膦酸盐相关颌骨坏死(BRONJ)的治疗。一项批判性综述。
Minerva Stomatol. 2010 Apr;59(4):181-203, 204-13.
10
Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.拔牙作为癌症患者双膦酸盐相关颌骨坏死的危险因素:最新进展
Odontostomatol Trop. 2013 Jun;36(142):38-46.

引用本文的文献

1
Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.骨髓多能间充质基质细胞作为骨坏死的自体治疗:年龄和潜在病因的影响
Bioengineering (Basel). 2021 May 17;8(5):69. doi: 10.3390/bioengineering8050069.

本文引用的文献

1
Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis.不同剂量唑来膦酸在双膦酸盐相关骨坏死形成中的作用
Arch Oral Biol. 2015 Sep;60(9):1237-45. doi: 10.1016/j.archoralbio.2015.05.015. Epub 2015 Jun 6.
2
High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.高剂量双膦酸盐通过使细胞周期停滞并诱导细胞凋亡来降低成骨样细胞的增殖。
J Craniomaxillofac Surg. 2015 Apr;43(3):396-401. doi: 10.1016/j.jcms.2014.12.008. Epub 2014 Dec 19.
3
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
美国口腔颌面外科医师协会关于药物相关性颌骨坏死的立场文件——2014年更新版
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5.
4
Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report.韩国双膦酸盐相关颌骨坏死:初步报告。
J Korean Assoc Oral Maxillofac Surg. 2013 Feb;39(1):9-13. doi: 10.5125/jkaoms.2013.39.1.9. Epub 2013 Feb 21.
5
Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays.双膦酸盐相关颌骨坏死:药物假期的一种潜在替代方案。
Gen Dent. 2013 Aug;61(5):33-8.
6
Safety issues with bisphosphonate therapy for osteoporosis.双膦酸盐治疗骨质疏松症的安全性问题。
Rheumatology (Oxford). 2014 Jan;53(1):19-31. doi: 10.1093/rheumatology/ket236. Epub 2013 Jul 9.
7
The kidney and bisphosphonates.肾脏与双膦酸盐。
Bone. 2011 Jul;49(1):77-81. doi: 10.1016/j.bone.2010.12.024. Epub 2011 Jan 11.
8
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.接受 5 毫克唑来膦酸治疗的患者发生颌骨坏死的发生率:来自健康结局和唑来膦酸每年一次临床研究计划降低发生率的数据。
J Am Dent Assoc. 2010 Nov;141(11):1365-70. doi: 10.14219/jada.archive.2010.0082.
9
Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospital.与静脉注射双膦酸盐相关的颌骨骨坏死:一家约旦教学医院的经验
Ann R Coll Surg Engl. 2010 Sep;92(6):489-94. doi: 10.1308/003588410X12699663903395. Epub 2010 Jun 1.
10
Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.双膦酸盐相关性颌骨骨坏死癌症患者的危险因素的纵向队列研究。
J Clin Oncol. 2009 Nov 10;27(32):5356-62. doi: 10.1200/JCO.2009.21.9584. Epub 2009 Oct 5.